Energy policy was one of the top items on President Trump’s agenda during his successful presidential campaign, and his election on November 8th of last year sent shockwaves throughout global energy markets. In the month following the presidential election, the S&P 500 Energy Index (INDEXSP:SP500-10) gained roughly 9%, while the Dow Jones U.S. Coal Index (INDEXDJX:DJUSCL) rode the momentum....More>>>
On the first day of 2008, the Greek stock index opened the new year at 1,036 points. In early 2016, it bottomed out – at 15. (Yes, 15!) It's true… The MSCI Greece Index fell by more than 1,000 points (in U.S.-dollar terms). Ultimately, it was a 98.5% fall, peak to trough. Take a look… So let me ask you a simple math question here… ....More>>>
Texas Instruments Inc. (NASDAQ: TXN) has done well, along with the broader market and semiconductor stock rally. With a gain of 11% so far in 2017, its performance is quite similar to that of the Van Eck Semiconductors index ETF and the Nasdaq 100. Still, that is twice the gain of the S&P 500.
Bank of America Merrill Lynch’s global research team has this week published a list of....More>>>
Buying the right dog for you and your family is always an extremely important decision. There’s a lot to consider the pup’s temperament, how big he’ll grow to be versus your living arrangements, and the cost of upkeep and medical care. Granted you should always consider adopting from your local shelter, because it’ll save both the dog and some cash for you,....More>>>
European Pressphoto Agency
An upbeat reading on U.S. retail sales isnt enough to keep U.S. stock indices from tanking today. The Dow dropped more than 200points in late afternoon market action.
The Dow Jones Industrial Average dropped 1.19% and the S&P 500 fell 1% while the Nasdaq Composite fell 0.6%.
Energy and financial shares in the S&P 500 led the declines with the....More>>>
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is watching its shares drop on Tuesday after the company provided an update on its regulatory pathway for its Fabry Disease treatment. After the company had several collaborative discussions with the U.S. Food and Drug Administration (FDA), Amicus plans to collect additional data on gastrointestinal (GI) symptoms in Fabry patients who have an amenable mutation.
By Michael Corcoran
The year just ended was a happier one for energy investors than the one prior. Despite a volatile ride, oil prices managed to recover from February lows and ended the year at a high.
The year-end rally was spurred by Donald Trump’s surprise election victory and the market’s subsequent anticipation of accelerated economic growth and hence increased oil....More>>>
Regeneron Pharmaceuticals (REGN) soared to the top of the S&P 500 today after a competitor’s competing drug failed a Phase 3 trial.
Regenerongained 3.8% to $387.10 today, while the S&P 500 declined 0.1% to 2,256.96.
RBC’s Adnan Butt and Michael Yee offer their take:
Two Phase 3 studies comparing Ophthotechs (OPHT) Fovista plus Lucentis....More>>>
By Lynnette Khalfani-Cox, The Money Coach
No matter which phase of life you’re currently in, how much money you presently earn or what level of assets you’ve accumulated so far, you can likely benefit from improving some aspect of your personal finances.
Here are six key money rules to follow that will take your finances to the next level.
Rule #1: Practice tax....More>>>